28 results
SC 14D9/A
PNT
POINT Biopharma Global Inc.
18 Dec 23
Tender offer solicitation (amended)
8:14am
of which is then capable of being satisfied), other than the Antitrust Condition, the NRC Condition and the condition requiring the absence of any Legal
SC 14D9/A
PNT
POINT Biopharma Global Inc.
4 Dec 23
Tender offer solicitation (amended)
7:22am
are to be satisfied at the Acceptance Time, each of which is then capable of being satisfied), other than the Antitrust Condition, the NRC Condition
SC 14D9/A
PNT
POINT Biopharma Global Inc.
17 Nov 23
Tender offer solicitation (amended)
7:05am
that by their nature are to be satisfied at the Acceptance Time, each of which is then capable of being satisfied), other than the Antitrust
SC 14D9/A
PNT
POINT Biopharma Global Inc.
8 Nov 23
Tender offer solicitation (amended)
5:28pm
that by their nature are to be satisfied at the Acceptance Time, each of which is then capable of being satisfied), other than the Antitrust Condition … :
The last paragraph under the subsection titled “U.S. Antitrust Laws” within the section titled “Regulatory Approvals” on page 43 is hereby deleted
SC TO-T/A
q8j1hraf4hfs
8 Nov 23
Third party tender offer statement (amended)
5:06pm
SC 14D9
gvj8dkryk89 l5tottp
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
EX-99
ixshdghu8c nd9m
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
ayapa3z fgvv6
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
27js20ttb2us s7vamt
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-2.1
5gyzxk twau2
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
jf87a ubiv
3 Oct 23
Tender and Support Agreement
7:35am
8-K
dr1a5fgj74
3 Oct 23
Tender and Support Agreement
7:35am
ARS
06unmt0ey1574j96f2k2
1 May 23
Annual report to shareholders
1:52pm
424B3
94np46
9 Jun 21
Prospectus supplement
4:42pm